AGENDA
NETWORKING
ADMIN DETAILS
SUPPORTERS
Speakers
| SPEAKING FACULTY |
| Special Guests |
| Dick Vitale, Legendary College Basketball Coach/Analyst/Advocate, Board of Directors, V Foundation for Cancer Research |
| Elizabeth Edwards, Breast Cancer Survivor, Wife of Presidential Candidate John Edwars, Author, Saving Graces |
| C-Level Round-Up |
| Alan Breier, MD, Vice President, Medical and Chief Medical Officer, Eli Lilly & Co |
| Christopher Gallen, MD, PhD, President and Chief Executive Officer, Neuromed Pharmaceuticals |
| John Crowley, JD, MBA, President & Chief Executive Officer, Amicus Therapeutics Timothy Tyson, President and Chief Executive Officer, Valeant Pharmaceuticals |
| Featured Keynote Faculty |
| Alan Roses, MD, FRCP (Hon), Senior Vice President, Pharmacogenetics, GlaxoSmithKline |
| Barry Sachais, Vice President, Clinical Development, Neuromed Pharmaceuticals |
| Claudia R. Turner, PhD, Executive Director, Safety and Risk Management, Pfizer Inc |
| Eleanor S. Segal, MD, VP and Head, Global Drug Safety and Global Medical Information, Actelion Pharmaceuticals |
| Ira Spector, Vice President, Clinical Development Operations and Vice Chief of Operations, Wyeth Pharmaceuticals |
| Mark Bach, PhD, Vice President, Clinical Research Operations Worldwide, Merck & Co Inc |
| Mathias Hukkelhoven, PhD, Senior Vice President, Global Head of Drug Regulatory Affairs, Novartis Pharmaceuticals Corporation |
| Michael D. Blum, MD, MPH, Vice President, Medical Pharmacovigilance, Global Safety Surveillance and Epidemiology, Wyeth Research |
| Nadine Cohen, PhD, Head of Pharmacogenomics and Senior Research Fellow, Johnson & Johnson PRD, Elected Chair, Industry Pharmacogenetics Working Group |
| Patrick M. Caubel, Associate Vice President, Head of Pharmacovigilance North America, Sanofi-Pasteur |
 |
| Pharmaceutical / Biotech Executives |
| Adam Ruskin, PhD, DVM, MPH, Director of Clinical Research, Maxygen, Inc |
| Allan M. Cohen, Director of Legal Services, Celtic Pharma |
| Andrew Townshend, Senior Director, Contracts and Outsourcing, Pfizer Inc |
| Carol Fouts-Johnson, Area Quality Control (AQC) Consultant, Eli Lilly and Company |
| Chris Popple, Manager, Clinical Demand Planning, MedImmune, Inc |
| Christine Cioffe, Vice President, R&D Portfolio Management, Merck & Co |
| Colleen McCoy, Senior Manager, Development Outsourcing and Contracts, Genentech, Inc. |
| David B. Snead, Ph.D., Associate Director, Biostatistics, Centocor R&D, Inc |
| Edmund Tsuei, Regional Head, Pharma Development Operations, Asia-Pacific-Africa, Roche Products Pty Limited |
| Edward Mannello, Study Recruitment Center, Director, AstraZeneca |
| Gangadhar Sunkara, Ph, MBA, Associate Director, Novartis Pharmaceuticals Graeme Currie, PhD, Vice President, Clinical Operations, PDL BioPharma |
| Grant Morgan, PhD, Leader of R&D Metrics and Capacity Management; Senior Global Project Manager, Allergan, Inc |
| Helen Niu, MD, PhD, Director, Global Development Operations, Amgen, Inc |
| Ian C.Lauf, Manager, Clinical Trial Costing & Contract Development, Boehringer Ingelheim Pharmaceuticals, Inc Jane Myles, Associate Director, Clinical Operations, Genentech |
| Jean Pierre Bizzare, Vice President Clinical Oncology, Sanofi-Aventis |
| Jeff Marquis, Clinical Outsourcing Manager, Development Outsourcing and Contracts, Genentech, Inc Jeffrey S. Handen, Ph.D., Director, R&D Portfolio Management, Merck & Co, Inc |
| Jim Kremidas, Global Enrollment Optimization, Eli Lilly & Co |
| Kendra B. Eager, Ph.D., Assistant Vice President, Alliance Management, Wyeth Pharmaceuticals |
| Kunal Jaiswal, Associate Director, Clinical Supply Chain, Schering Plough Corporation Larry A. Blankstein, PhD, Senior Director, Clinical Research, Genzyme Corporation |
| Kunal Jaiswal, Associate Director, Clinical Supply Chain, Schering Plough Corporation |
| Larry A. Blankstein, PhD, Senior Director, Clinical Research, Genzyme Corporation |
| Leigh-Ann M. Durant, Associate General Counsel of Clinical Trials and Medical Affairs, EMD Serono, Inc. |
| Marisa F. Bower, CCOG, Manager, Vendor Outsourcing Division, Clinical Contracts and Outsourcing, Wyeth Research |
| Mark Horn, Director, Finance and R&D Portfolio Management, Wyeth Consumer Healthcare |
| Mark T. Ridge, MBA, Director, Global Enrollment Planning & Performance, Wyeth |
| Melissa Marshall, Assistant Director, Global Enrollment Planning & Performance, Wyeth |
| Pam Schroeder, Paralegal Supervisor, Abbott Laboratories |
| Pamela A. Rose, RN, FNP, ASQ CMQOE, Director, Clinical Trial Information Registries, TAP Pharmaceutical Products Inc |
| Pritesh Shah, MS, MBA, PMP, Project Lead, Metrics, Merck & Co, Inc |
| Rhoda Mull, JD, Senior Contracts and Finance Specialist, AstraZeneca |
| Richard Marshak, General Manager, AllianceManagement, Abbott |
| Robert diCicco, Vice President, Alliance Management and Project Management, Center for Excellence for External Drug Discovery, GlaxoSmithKline |
| Robert Friedman, Oncology Medical Development Center, Asst Director, Clinical Development, GlaxoSmithKline |
| Robin A. Myers, Associate Director, Clinical Study Planning & Resourcing, Global Clinical Program and Resource Management, Bayer Healthcare Pharmaceuticals Sailaja Bhaskar RPh, PhD, Senior Director, Clinical Operations, JDS Pharmaceuticals |
| Scott Jensen, Manager, Global Clinical Budgeting and Contracting, Eli Lilly & Co |
| Steve Pascoe, Head of Respiratory Translational Medicine, Novartis |
| William Jacobson, PhD, Director, Project Management, Wyeth Global Drug Development Training Program, Wyeth Pharmaceuticals |
| Zili Li, MD, MPH, Director of Clinical Research Operations - Asia Pacific/Head of MSD China Regulatory Policy Group, Merck & Co, Inc |
| Solution Providers /Consultants /Associations |
| Bill Gwinn, MBA, Vice President, Product Marketing, Inclinix |
| Bryan McIntyre, Senior Sales and Marketing Advisor, Inclinix |
| Daniel M. Ulrey, President and Chief Executive Officer, MCSI |
| Dave Zuckerman, President, Customized Improvement Strategies LLC |
| Francis P. Crawley, Executive Director, Good Clinical Practice Alliance - Europe & Member, Scientific Advisory Group, International Clinical Trial Registry Platform, World Health Organization |
| Gary Tyson, Senior Vice President, Clinical Development Practice, Campbell Alliance |
| Graham Bunn, Vice President of Global CRO Partnerships, Medidata Solutions |
| John Orley, Product Manager, Clinical Management Applications, ArisGlobal LLC |
| Jonathan Barker, President and CEO, TrialStat |
| Julie Ross, Executive Vice President, Essential Group, Inc. |
| Lawrence Oliver, PhD, Scientific Director of Mayo Clinical Trial Services, Department of Laboratory Medicine and Pathology at Mayo Clinic |
| Mark A. DeWyngaert PhD MBA, Managing Director, Huron Consulting Group |
|
Matt Kibby, Leader, Global Operations, BBK Worldwide Michelle Gray, Consultant, Formerly of Rinat Pfizer |
| Pam DePierre, Director, National Life Sciences Practice, Huron Consulting Services, LLC |
| Paul Smith, Chief Operating Officer, Provisio, Inc. |
| Rick Malcolm, PhD, Chief Executive Officer, Acurian, Inc |
| Tim Dietlin, Vice President, Clinical Development Practice, Campbell Alliance |
| Vivek Soneja, Director, Huron Consulting Group |
TAKE ACTION
QUESTIONS?
Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200
Need Technical Assistance With this Website?
Send an email to IIR's Web Department